Dr. Rocklage has over three decades of healthcare experience. During those years his leadership led to the approval of three U.S. drug Applications. Before partnering with 5AM Ventures he was CEO of companies such as Cubist Pharmaceuticals, Inc. and Nycomed Salutar, Inc. as well as holding executive positions in other companies. He has managed to raise over $500 million dollars for those companies through fund raisers. He holds a B.S. and Ph.D. in Chemistry from the University of California and the Massachusetts Institute of Technology and read full aritcle.
Dr. Scott Rocklage is now a managing partner at 5AM Ventures, where he joined in 2003. On the official 5AM Ventures website Dr. Rocklage is listed as one of three managing partners, along with Kush M. Parmar, MD, PhD and Andrew J Schwab. 5AM Ventures is a company that focuses on building next-generation life science companies. Life science companies are those that include the fields of biotechnology, pharmaceuticals, biomedical technologies, environmental, etc. In short these sciences have to do with “organisms” such as animals, plants and human beings. 5AM Ventures is involved with the strategies, management recruiting, business development and fundraising of these companies. They often are part of the process in that they take on short-term operating roles and learn more about Scott.
Their objective is to help these companies with funding and management so that advancements in science such as cancer research can continue and prosper. Without companies such as 5AM Ventures, many research advancements would be stifled. Dr. Rocklage plays a pivotal role in overseeing these companies and projects within the companies to make sure this research continues and Scott’s lacrosse camp.
More visit: http://www.rennovia.com/team/scott-m-rocklage/